Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-21-019134
Filing Date
2021-08-09
Accepted
2021-08-09 16:01:15
Documents
5
Period of Report
2021-09-07

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A atos20210809_def14a.htm DEF 14A 76863
2 a01.jpg GRAPHIC 328374
3 a02.jpg GRAPHIC 250571
4 logo.jpg GRAPHIC 11185
5 sig.jpg GRAPHIC 6165
  Complete submission text file 0001437749-21-019134.txt   893921
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35610 | Film No.: 211156341
SIC: 2834 Pharmaceutical Preparations